• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Harm Reduction Therapeutics Donates RiVive Naloxone on Overdose Awareness Day

    GLOBENEWSWIRE

    Harm Reduction Introduces RiVive, OTC Opioid Overdose Reversal Medication

    BUSINESSWIRE

    US FDA approves second over-the-counter opioid overdose reversal drug

    REUTERS

    Harm Reduction Therapeutics to Receive Additional Funding for its Low-Cost Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma

    BUSINESSWIRE

    Harm Reduction Therapeutics` NDA for RiVive™ OTC Naloxone Nasal Spray

    PRNEWSWIRE

    Naloxone Initiates a Rolling Submission of its NDA to U.S.FDA for RiVive

    PRNEWSWIRE

    Harm Reduction Therapeutics Signs Supply Agreement for Fast Tracked Naloxone

    PRNEWSWIRE

    Purdue shells out a little more cash for naloxone OTC nasal spray

    ENDPTS

    HRT to Receive Additional Funding for OTC Naloxone Nasal Spray

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.